AstraZeneca – FDA Approval of Saphnelo™ (anifrolumab) For Lupus Erythematosus (SLE)
Richard Furie, Chief, Division of Rheumatology, Northwell Health, and principal investigator in the Saphnelo™ (anifrolumab) clinical trials for the...
5240 articles
Richard Furie, Chief, Division of Rheumatology, Northwell Health, and principal investigator in the Saphnelo™ (anifrolumab) clinical trials for the...
Ada Kumar, Medical Director in Medical Affairs at Horizon Therapeutics discusses recent findings from "Rheumatology" (July 10, 2021) which showed an "ur...
The COVID-19 pandemic has dramatically decreased blood donations, especially those for plasma. Thousands of patients rely on plasma-derived therapies ...
William Haseltine, President, Access Health International, discusses his latest book "Science as a Superpower: My Lifelong Fight Against Disease and the...
Mark Rothera, President and CEO of Silence Therapeutics discusses RNAi research and how the company is applying its mRNAi GOLD™ platform to precisely ...
Clinicians are acutely interested in delivering the best outcomes for their patients. Learn more on Health Professional Radio.
Alison Miles, a patient living with Pompe disease, a condition that develops when the body can't make a protein that breaks down a complex sugar, glycog...
Devon Christie, MD, is the Medical and Therapeutic Services Director with Numinus Wellness Inc., a Canadian-based company at the forefront of advancing ...
Hematology and Oncology at Jazz Pharmaceuticals, discusses the "Nothing Small About It" online program developed with leading cancer organizations focus...
Jared Silver, MD, PhD, Allergist Immunologist & Indication Lead for Mepolizumab, US Medical Affairs Respiratory at GSK discusses the recent FDA approval...